SS
AUPH icon

SBI Securities’s Aurinia Pharmaceuticals AUPH Stock Holding History

SBI Securities’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.44K Hold
203
– – ﹤0.01% 2342
2026
Q1 		$3.01K Sell
203
-21
-9% -$307 ﹤0.01% 2258
2025
Q4 		$3.57K Buy
224
+223
+22,300% +$3.16K ﹤0.01% 2161
2025
Q3 		$11 Hold
1
– – ﹤0.01% 4020
2025
Q2 		$8 Hold
1
– – ﹤0.01% 4033
2025
Q1 		$8 Sell
1
-2,833
-100% -$23K ﹤0.01% 3985
2024
Q4 		$25.4K Buy
+2,834
New +$23.1K ﹤0.01% 1245

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SBI Securities's AUPH Position: Q2 2026 in Review

SBI Securities held its Aurinia Pharmaceuticals (AUPH) position steady in Q2 2026 at 203 shares worth $3.44K. The position accounts for ﹤0.01% of the portfolio, ranked #2342.

SBI Securities first reported a position in AUPH in Q4 2024 and has held it in 7 quarters since. The position peaked at $25.4K in Q4 2024. 281 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • SBI Securities held 203 shares of Aurinia Pharmaceuticals worth $3.44K as of Q2 2026.
  • SBI Securities left its Aurinia Pharmaceuticals share count unchanged in Q2 2026.
  • Aurinia Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2342 holding.
  • SBI Securities first reported a position in Aurinia Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Aurinia Pharmaceuticals position peaked at $25.4K in Q4 2024.
  • 281 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.